Artara Therapeutics
Permanently closed
1 Little West 12th St
New York, NY 10014
Protara Therapeutics Inc. is a New York-based biopharmaceutical company focused on developing transformative therapies for patients with rare diseases. Their lead investigational cell therapy, TARA-002, targets non-muscle invasive bladder cancer and lymphatic malformations and has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration.
In addition to TARA-002, Protara is advancing IV Choline Chloride, an investigational therapy aimed at addressing choline deficiency in patients on parenteral support. This product has the potential to become the first FDA-approved intravenous choline formulation for this patient population.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Foursquare.
